Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
394.52
398.41
389.58
316.76
314.82
219.89
256.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
394.52
398.41
389.58
316.76
314.82
219.89
256.71
Raw Material Cost
193.15
163.29
162.25
129.53
105.48
81.15
85.97
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.42
3.04
2.81
2.09
1.24
1.89
1.38
Selling and Distribution Expenses
137.31
146.85
131.39
109.74
95.15
65.43
75.43
Other Expenses
4.02
3.85
3.98
3.34
2.82
2.07
2.26
Total Expenditure (Excl Depreciation)
373.11
351.73
336.28
274.76
230.04
169.15
185.42
Operating Profit (PBDIT) excl Other Income
21.400000000000002
46.7
53.3
42
84.80000000000001
50.7
71.3
Other Income
9.67
1.16
5.70
6.35
16.02
16.77
3.84
Operating Profit (PBDIT)
97.03
99.35
106.34
86.14
126.39
83.54
88.98
Interest
2.42
3.04
2.81
2.09
1.24
1.89
1.38
Exceptional Items
0.00
-1.10
0.43
0.22
0.01
0.00
0.00
Gross Profit (PBDT)
201.37
235.12
227.33
187.22
209.34
138.73
170.75
Depreciation
69.79
54.18
47.34
37.79
26.03
16.55
14.27
Profit Before Tax
24.82
41.03
56.63
46.48
99.13
65.10
73.33
Tax
1.62
4.23
9.29
4.83
12.93
8.49
9.72
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
23.20
36.80
47.33
41.65
86.19
56.62
63.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
23.20
36.80
47.33
41.65
86.19
56.62
63.84
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
23.20
36.80
47.33
41.65
86.19
56.62
63.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
820.01
812.14
810.73
779.36
770.00
206.29
149.64
Earnings per share (EPS)
0.37
0.58
0.74
0.66
1.37
0.9
1.01
Diluted Earnings per share
0.37
0.58
0.74
0.66
1.37
0.9
1.01
Operating Profit Margin (Excl OI)
4.46%
11.05%
13.68%
13.26%
26.79%
22.84%
27.6%
Gross Profit Margin
23.98%
23.9%
26.69%
26.6%
39.76%
37.13%
34.12%
PAT Margin
5.88%
9.24%
12.15%
13.15%
27.38%
25.75%
24.87%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -0.98% vs 2.26% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -36.96% vs -22.20% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -11.00% vs -2.39% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -20.00% vs 7.14% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of HOB Biotech Group Corp. Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
394.52
0
394.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
394.52
0
394.52
Raw Material Cost
193.15
0
193.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.42
0
2.42
Selling and Distribution Expenses
137.31
0
137.31
Other Expenses
4.02
0.00
4.02
Total Expenditure (Excl Depreciation)
373.11
0
373.11
Operating Profit (PBDIT) excl Other Income
21.41
0.00
21.41
Other Income
9.67
0
9.67
Operating Profit (PBDIT)
97.03
0
97.03
Interest
2.42
0
2.42
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
201.37
0
201.37
Depreciation
69.79
0
69.79
Profit Before Tax
24.82
0
24.82
Tax
1.62
0
1.62
Provisions and contingencies
0
0
0.00
Profit After Tax
23.20
0
23.20
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
23.20
0
23.20
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
23.20
0
23.20
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
820.01
0
820.01
Earnings per share (EPS)
0.37
0
0.37
Diluted Earnings per share
0.37
0
0.37
Operating Profit Margin (Excl OI)
4.46%
0%
0.00
4.46%
Gross Profit Margin
23.98%
0%
0.00
23.98%
PAT Margin
5.88%
0%
0.00
5.88%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 39.45 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -0.98% vs 2.26% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 2.32 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -36.96% vs -22.20% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 8.74 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -11.00% vs -2.39% in Dec 2024
Annual - Interest
Interest 0.24 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -20.00% vs 7.14% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 4.46%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






